Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Change in Acquisitions & Divestments: 2016-2024

Historic Change in Acquisitions & Divestments for Tvardi Therapeutics (TVRD) over the last 9 years, with Dec 2024 value amounting to $82.0 million.

  • Tvardi Therapeutics' Change in Acquisitions & Divestments fell 19.20% to $16.8 million in Q4 2017 from the same period last year, while for Dec 2017 it was $82.2 million, marking a year-over-year increase of 2.21%. This contributed to the annual value of $82.0 million for FY2024, which is 47.25% down from last year.
  • Latest data reveals that Tvardi Therapeutics reported Change in Acquisitions & Divestments of $82.0 million as of FY2024, which was down 47.25% from $155.4 million recorded in FY2023.
  • Over the past 5 years, Tvardi Therapeutics' Change in Acquisitions & Divestments peaked at $220.4 million during FY2022, and registered a low of $82.0 million during FY2024.
  • In the last 3 years, Tvardi Therapeutics' Change in Acquisitions & Divestments had a median value of $155.4 million in 2023 and averaged $152.6 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first grew by 27.06% in 2022, then crashed by 47.25% in 2024.
  • Tvardi Therapeutics' Change in Acquisitions & Divestments (Yearly) stood at $144.3 million in 2020, then climbed by 20.21% to $173.5 million in 2021, then grew by 27.06% to $220.4 million in 2022, then dropped by 29.48% to $155.4 million in 2023, then tumbled by 47.25% to $82.0 million in 2024.